The protective anti-inflammatory action of ANXA1 has since been demonstrated in several models, including arthritis, heterologous skin transplantation, cancer, eye allergy, heart failure, lung injury, nonalcoholic steatosis, myocardial infarction, and skeletal muscle injury [19,20,21,22,23,24,25,26,27,28,29,30]. The gene discussed is ANXA1; the disease is cancer.